Dr
Véronique BREUIL
Publications récentes
Roux
C, Fontas E, Breuil V, Brocq O, Albert C, Euller-Ziegler L. Injection of intra-articular
sodium hyaluronidate (Sinovial) into the carpometacarpal joint of the thumb (CMC1)
in osteoarthritis. A prospective evaluation of efficacy. Joint Bone Spine. 2007;74(4):368-72
Brocq
O, Roux CH, Albert C, Breuil V, Aknouche N, Ruitord S, Mousnier A, Euller-Ziegler
L. TNFalpha antagonist continuation rates in 442 patients with inflammatory joint
disease. Joint Bone Spine. 2007;74(2):148-54
Roux
CH, Brocq O, Leccia N, Giacchero D, Breuil V, Albert C, Lacour J, Perrin C, Euler-Ziegler
L. New-onset psoriatic palmoplantaris pustulosis following infliximab therapy:
a class effect? J Rheumatol. 2007;34(2):434-7.
Roux
CH, Brocq O, Breuil V, Albert C, Euller-Ziegler L. Pregnancy in rheumatology patients
exposed to anti-tumour necrosis factor (TNF)-alpha therapy. Rheumatology (Oxford).
2007;46(4):695-8
Roux
CH, Breuil V, Brocq O, Albert C, Chami H, Euller-Ziegler L. Hyperamylasemia and
back pain: an exceptional association revealing multiple myeloma. Joint Bone Spine.
2007;74(1):112-3
Breuil
V, Euller-Ziegler L. Bisphosphonate therapy in rheumatoid arthritis. Joint Bone
Spine. 2006;73(4):349-54
Roux
CH, Brocq O, Breuil V, Albert C, Euller-Ziegler L. Safety of anti-TNF-alpha therapy
in rheumatoid arthritis and spondylarthropathies with concurrent B or C chronic
hepatitis. Rheumatology (Oxford). 2006;45(10):1294-7
Roux
CH, Chami H, Breuil V, Brocq O, Albert C, Euller-Ziegler L. Lumbosacral pain:
chordoma--a diagnosis not to forget. Clin Rheumatol. 2007;26(5):781-3
Blin-Wakkach
C, Breuil V, Quincey D, Bagnis C, Carle GF. Establishment and characterization
of new osteoclast progenitor cell lines derived from osteopetrotic and wild type
mice. Bone. 2006;39(1):53-60
Roux
CH, Breuil V, Brocq O, Euller-Ziegler L. Pleural amyloidosis as the first sign
of IgD multiple myeloma. Clin Rheumatol. 2005;24(3):294-5
Brocq
O, Albert C, Roux C, Gerard D, Breuil V, Ziegler LE. Adalimumab in rheumatoid
arthritis after failed infliximab and/or etanercept therapy: experience with 18
patients. Joint Bone Spine. 2004;71(6):601-3
Vitale
S, Schmid-Alliana A, Breuil V, Pomeranz M, Millet MA, Rossi B, Schmid-Antomarchi
H. Soluble fractalkine prevents monocyte chemoattractant protein-1-induced monocyte
migration via inhibition of stress-activated protein kinase 2/p38 and matrix metalloproteinase
activities. J Immunol. 2004;172(1):585-92
Breuil
V, Schmid-Antomarchi H, Schmid-Alliana A, Rezzonico R, Euller-Ziegler L, Rossi
B. The receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) is a new
chemotactic factor for human monocytes. FASEB J. 2003;17(12):1751-3
Brocq
O, Tran G, Breuil V, Grisot C, Flory P, Euller-Ziegler L. Hip osteoarthritis:
short-term efficacy and safety of viscosupplementation by hylan G-F 20. An open-label
study in 22 patients. Joint Bone Spine. 2002;69(4):388-91
Rezzonico
R, Schmid-Alliana A, Romey G, Bourget-Ponzio I, Breuil V, Breittmayer V, Tartare-Deckert
S, Rossi B, Schmid-Antomarchi H. Prostaglandin E2 induces interaction between
hSlo potassium channel and Syk tyrosine kinase in osteosarcoma cells. J Bone Miner
Res. 2002;17(5):869-78
Breuil
V, Brocq O, Pellegrino C, Grimaud A, Euller-Ziegler L. Erdheim-Chester disease:
typical radiological bone features for a rare xanthogranulomatosis. Ann Rheum
Dis. 2002;61(3):199-200
Breuil
V, Euller-Ziegler L. Gonadal dysgenesis and bone metabolism. Joint Bone Spine.
2001;68(1):26-33
Xia
L, Kilb J, Wex H, Li Z, Lipyansky A, Breuil V, Stein L, Palmer JT, Dempster DW,
Brömme D. Localization of rat cathepsin K in osteoclasts and resorption pits:
inhibition of bone resorption and cathepsin K-activity by peptidyl vinyl sulfones.
Biol Chem. 1999;380(6):679-87
